Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
The Journal of Clinical Investigation|January 31, 2017
A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancerChiara Berlato, Moddasar N Khan, Tiziana Schioppa, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
IgE-antibody-dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cellsSophia N Karagiannis, Marguerite G Bracher, James Hunt, et al.Cancer Research|March 17, 2006
10th Biennial Helene Harris Memorial Trust meetingFrances R Balkwill, Alan Ashworth, Robert C Bast, et al.The Journal of Pathology|September 10, 2013
Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblastsTat-San Lau, Tony Kwok-Hung Chung, Tak-Hong Cheung, et al.Cancer Research|September 25, 2021
TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian CancerLaura S M Lecker, Chiara Berlato, Eleni Maniati, et al.Cell Reports|January 16, 2020
Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to TreatmentEleni Maniati, Chiara Berlato, Ganga Gopinathan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2011
Interleukin-6 as a therapeutic target in human ovarian cancerJermaine Coward, Hagen Kulbe, Probir Chakravarty, et al.Cancer Research|November 9, 2011
A dynamic inflammatory cytokine network in the human ovarian cancer microenvironmentHagen Kulbe, Probir Chakravarty, D Andrew Leinster, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous CarcinomaSteffen Böhm, Anne Montfort, Oliver M T Pearce, et al.Cancer Discovery|June 30, 2022
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1βIrene Olivera, Rebeca Sanz-Pamplona, Elixabet Bolaños, et al.Pageof 8